JFS Wealth Advisors’s Acer Therapeutics Inc. Common Stock (DE) ACER Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-24
| Closed | -$20 | – | 2059 |
|
2023
Q3 | $20 | Hold |
24
| – | – | ﹤0.01% | 1957 |
|
2023
Q2 | $23 | Hold |
24
| – | – | ﹤0.01% | 1968 |
|
2023
Q1 | $19 | Hold |
24
| – | – | ﹤0.01% | 1943 |
|
2022
Q4 | $60 | Hold |
24
| – | – | ﹤0.01% | 1912 |
|
2022
Q3 | $0 | Hold |
24
| – | – | ﹤0.01% | 1972 |
|
2022
Q2 | $0 | Hold |
24
| – | – | ﹤0.01% | 1985 |
|
2022
Q1 | $0 | Hold |
24
| – | – | ﹤0.01% | 2008 |
|
2021
Q4 | $0 | Hold |
24
| – | – | ﹤0.01% | 1929 |
|
2021
Q3 | $0 | Hold |
24
| – | – | ﹤0.01% | 851 |
|
2021
Q2 | $0 | Hold |
24
| – | – | ﹤0.01% | 647 |
|
2021
Q1 | $0 | Hold |
24
| – | – | ﹤0.01% | 637 |
|
2020
Q4 | $0 | Hold |
24
| – | – | ﹤0.01% | 645 |
|
2020
Q3 | $0 | Hold |
24
| – | – | ﹤0.01% | 607 |
|
2020
Q2 | $0 | Hold |
24
| – | – | ﹤0.01% | 588 |
|
2020
Q1 | $0 | Hold |
24
| – | – | ﹤0.01% | 581 |
|
2019
Q4 | $0 | Hold |
24
| – | – | ﹤0.01% | 559 |
|
2019
Q3 | $0 | Hold |
24
| – | – | ﹤0.01% | 542 |
|
2019
Q2 | $0 | Hold |
24
| – | – | ﹤0.01% | 490 |
|
2019
Q1 | $1K | Hold |
24
| – | – | ﹤0.01% | 455 |
|
2018
Q4 | $0 | Hold |
24
| – | – | ﹤0.01% | 551 |
|
2018
Q3 | $1K | Hold |
24
| – | – | ﹤0.01% | 515 |
|
2018
Q2 | $1K | Hold |
24
| – | – | ﹤0.01% | 448 |
|
2018
Q1 | $0 | Hold |
24
| – | – | ﹤0.01% | 578 |
|
2017
Q4 | $0 | Hold |
24
| – | – | ﹤0.01% | 563 |
|
2017
Q3 | $0 | Hold |
24
| – | – | ﹤0.01% | 464 |
|
2017
Q2 | $0 | Hold |
24
| – | – | ﹤0.01% | 458 |
|
2017
Q1 | $0 | Hold |
24
| – | – | ﹤0.01% | 447 |
|
2016
Q4 | $0 | Hold |
24
| – | – | ﹤0.01% | 496 |
|
2016
Q3 | $1K | Hold |
24
| – | – | ﹤0.01% | 468 |
|
2016
Q2 | $1K | Buy |
+24
| New | +$1K | ﹤0.01% | 483 |
|